Laboratory Outcome Predictors in Coronary Surgery
Markers of Tissue Perfusion as Predictors of Complicated Evolution in Patients With Left Ventricular Dysfunction Submitted to Coronary Artery Bypass Surgery
1 other identifier
observational
87
1 country
1
Brief Summary
Evaluate less employed markers of tissue hypoperfusion as venoarterial carbon dioxide partial pressure difference (ΔPCO2) and estimated respiratory quotient (eRQ) combined to other classically studied markers as predictive factors of complicated clinical course after cardiac surgery in patients with left ventricular dysfunction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2006
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2008
CompletedFirst Submitted
Initial submission to the registry
August 9, 2010
CompletedFirst Posted
Study publicly available on registry
August 10, 2010
CompletedAugust 10, 2010
January 1, 2008
2 years
August 9, 2010
August 9, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Complicated clinical course after coronary artery bypass surgery
Complicated clinical course defined as death within the first 30 days after surgery or ICU stay more than 4 days.
within the first 30 days after surgery
Study Arms (1)
Clinical course
complicated course group (death within 30 days after surgery or ICU stay \> 4 days) and uncomplicated course group (ICU stay ≤ 4 days).
Eligibility Criteria
Adults undergoing coronary artery bypass surgery requiring the use of CPB
You may qualify if:
- adults
- left ventricular dysfunction (ejection fraction \< 50%)
- patients undergoing coronary artery bypass surgery requiring the use of Cardiopulmonary Bypass (CPB)
You may not qualify if:
- renal failure (creatinine clearance lower than 40 ml/min/m2),
- hepatic dysfunction
- endocrinologic disorders
- pulmonary disease
- uncontrolled diabetes mellitus
- a history of fever or infection within the week before surgery
- previous anemia (hemoglobin ≤ 10.0 g/dL)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Heart Institute, Hospital of Clinics, São Paulo University Medical School
São Paulo, São Paulo, 05403-000, Brazil
Related Publications (5)
Mekontso-Dessap A, Castelain V, Anguel N, Bahloul M, Schauvliege F, Richard C, Teboul JL. Combination of venoarterial PCO2 difference with arteriovenous O2 content difference to detect anaerobic metabolism in patients. Intensive Care Med. 2002 Mar;28(3):272-7. doi: 10.1007/s00134-002-1215-8. Epub 2002 Feb 8.
PMID: 11904655BACKGROUNDRanucci M, De Toffol B, Isgro G, Romitti F, Conti D, Vicentini M. Hyperlactatemia during cardiopulmonary bypass: determinants and impact on postoperative outcome. Crit Care. 2006;10(6):R167. doi: 10.1186/cc5113.
PMID: 17134504BACKGROUNDRanucci M, Isgro G, Romitti F, Mele S, Biagioli B, Giomarelli P. Anaerobic metabolism during cardiopulmonary bypass: predictive value of carbon dioxide derived parameters. Ann Thorac Surg. 2006 Jun;81(6):2189-95. doi: 10.1016/j.athoracsur.2006.01.025.
PMID: 16731152BACKGROUNDMeregalli A, Oliveira RP, Friedman G. Occult hypoperfusion is associated with increased mortality in hemodynamically stable, high-risk, surgical patients. Crit Care. 2004 Apr;8(2):R60-5. doi: 10.1186/cc2423. Epub 2004 Jan 12.
PMID: 15025779BACKGROUNDTopkara VK, Cheema FH, Kesavaramanujam S, Mercando ML, Cheema AF, Namerow PB, Argenziano M, Naka Y, Oz MC, Esrig BC. Coronary artery bypass grafting in patients with low ejection fraction. Circulation. 2005 Aug 30;112(9 Suppl):I344-50. doi: 10.1161/CIRCULATIONAHA.104.526277.
PMID: 16159844BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thiana Yamaguti, PhD
Heart Institute, Hospital of Clinics, São Paulo University Medical School
- STUDY CHAIR
José Otávio C. Auler Júnior, PhD/Chairman
Heart Institute, Hospital of Clinics, São Paulo University Medical School
- STUDY DIRECTOR
Marilde A. Piccioni, PhD
Heart Institute, Hospital of Clinics, São Paulo University Medical School
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 9, 2010
First Posted
August 10, 2010
Study Start
January 1, 2006
Primary Completion
January 1, 2008
Study Completion
March 1, 2008
Last Updated
August 10, 2010
Record last verified: 2008-01